CN1382734A - Process for preparing human insuline from transgenic romaine lettuce - Google Patents

Process for preparing human insuline from transgenic romaine lettuce Download PDF

Info

Publication number
CN1382734A
CN1382734A CN 02104176 CN02104176A CN1382734A CN 1382734 A CN1382734 A CN 1382734A CN 02104176 CN02104176 CN 02104176 CN 02104176 A CN02104176 A CN 02104176A CN 1382734 A CN1382734 A CN 1382734A
Authority
CN
China
Prior art keywords
gene
insulin
except
romaine lettuce
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02104176
Other languages
Chinese (zh)
Inventor
林忠平
倪挺
胡鸢雷
高音
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02104176 priority Critical patent/CN1382734A/en
Publication of CN1382734A publication Critical patent/CN1382734A/en
Priority to CNB031195857A priority patent/CN100540666C/en
Pending legal-status Critical Current

Links

Images

Abstract

A process for preparing human insulin from transgenic romaine lettuce as a bioreactor which can be also used as a food to prevent and cure diabetes is disclosed. The human insulin gene is artificially synthesized through designing codon, synthesizing several DNA fragments, splicing them together and adding KDEL endoplasmic reticulum retention sequence to its terminal C. Under the drive of CaMV35S promoter, the said gene is transferred into ramaine lattuce and the human insulin is expressed in the leaves and stems of ramaine lattuce.

Description

Utilize transgenic lettuce production insulin human's method
The present invention utilizes romaine lettuce to come manufacturer's Regular Insulin as a kind of plant bioreactor.This insulin human can enter in the body by mucocutaneous membrane on the digestive tube as a kind of oral preparations by eating romaine lettuce raw, improves the autoimmunity situation of diabetic.Also can extract the insulin human of high expression level amount simultaneously, and obtain the injection insulin human from this romaine lettuce.
The point of main innovation of the present invention is that (1) select the codon of plant-preference for use, the synthetic human insulin gene; (2) add KDEL endoplasmic reticulum retention sequence at synthetic insulin human's C end, avoided the degraded of Regular Insulin in vegetable cell.
The research that utilizes potato tuber to produce Hepatitis B virus vaccine in plant bioreactor research has been subjected to paying attention to widely.Romaine lettuce is produced oral polypeptide drug with it and is had very big application potential as eating vegetables or fruit.The insulin human is crucial for the urine patient's of insulin-dependent treatment.Some diabetic subject's metabolism adjusting is relevant with the autoimmunity function.It is effective (Reddy S et at, Pancreas2000,20 (1): 55-60 that oral insulin has been proved to be sick treatment of the urine of some type; Ploix C et at, Diabetes 1999,48 (1) 2150-6; Ramiya VK, Maclaren NK, Horm Res 1997,48 suppl 4:67-70).
One of technical essential of this invention is the synthetic of insulin gene.Why not adopting natural human insulin's dna sequence dna, is because we adopt the codon of plant-preference can improve the expression amount of this gene in plant.The encoded amino-acid sequence of natural insulin A chain and B chain of our used human insulin gene, but the DNA sequence of DNA sequence and natural human insulin's gene and inequality.
Two of the main points of this invention are structures of plant expression vector pCAM35S-InsK.Be connected on the p11Z carrier human insulin gene InsK of synthetic and order-checking, downcut the CaMV 35S promoter from the pBI221 carrier then, place the upstream of insulin gene.CaMV 35S-InsK downcut be placed on before the no terminator of plant expression vector pCAMBIA1390, cut with PCR assay certificate vector construction correct through enzyme.
Three of the main points of this invention are the endoplasmic reticulum retention sequences that added KDEL at the C of human insulin gene end.Studies have shown that four aminoacid sequences that add KDEL at proteinic C end, this protein is stranded in the endoplasmic reticulum, thereby avoids being degraded in a large number.
Four of the main points of this invention are that agriculture bacillus mediated romaine lettuce transforms.Change plant expression vector pCAM35S-InsK freeze-thaw method over to Agrobacterium LBA4404.Agrobacterium breeds the back and cultivates altogether with the romaine lettuce blade in containing the YEB substratum of Streptomycin sulphate, the blade of cultivating callus occurs after placing for some time on the screening culture medium that contains Cb and Totomycin altogether, the callus differentiation grows seedling then, seedling is moved into respectively in the different bottles, identify positive plant through PCR, and further Southern blotting and ELISA evaluation.
In one embodiment of the invention, about synthesizing of human insulin gene, select the codon of plant-preference for use.In 63 bases of insulin human A chain, 13 bases have been changed for this reason.In 90 bases of B chain, change 18 bases, added 12 alkali yl coding endoplasmic reticulum retention sequence KDEL at 3 ' end in addition.We have designed 6 amino acid whose junction fragments between A chain and B chain.The principle of design of the amino acid kind of this junction fragment and order is to keep the natural Three Dimensions Structure of insulin human.We clone EcoRI and BamHI site in the pGEM-11Z carrier with comprise the insulin human A chain and B chain and the middle segment order of connection of synthetic, and are determined this plasmid called after p11Z-InsK through the analysis and the sequential analysis of plasmid enzyme restriction collection of illustrative plates.In this embodiment, the human insulin gene fragment can obtain by pcr amplification, during amplification, the primer of use is as follows: InsK 5 ': 5 '-GAT CCA TGT TCG TTA ACC AAC ACC-3 ' InsK 3 ': 5 '-CTC GTC CTT GTT GCA GTA GTT CTC-3 '.
In one embodiment of the invention, human insulin gene places under the regulation and control of composition type expression promoter CaMV35S promotor, changes in the intermediate carrier again.Further change binary expression vector again over to, finish the structure of a plant expression vector and (see the clone of human insulin gene of Fig. 1, synthetic and the structure schema of plant expression vector.Wherein human insulin gene is under the control of constitutive promoter CaMV35S).
The bacterial classification that this patent relates to is in China Committee for Culture Collection of Microorganisms's common micro-organisms center preservation, Zhong Guan-cun, unit address BeiJing, China, this microorganism classification name is called colon bacillus (Ecoli.), the preservation code name is p11Z-InsK, deposit number is CGMCC NO.0723, and preservation date is on March 8th, 2002.One, synthetic human insulin gene InsK sequence: 1 GATCCATGTT CGTTAACCAA CACCTTTGCG GATCTCACCT TGTTGAGGCT CTTTACCTTG61 TTTGCGGAGA GAGGGGATTC TTCTACACCC CAAAGACCGG AGGACCATCT GGAGGAGGAA121 TCGTTGAGCA ATGCTGCACC TCTATCTGCT CTCTTTACCA ACTTGAGAAC TACTGCAACA181 AGGACGAGCT TTAAG

Claims (6)

1, utilizes transgenic lettuce production recombinant human insulin's method.The gene that wherein is used to transform comprises that also acceptor also comprises other plants such as cucumber, Radix Dauci Sativae, tobacco except that romaine lettuce through insulin gene and the partial sequence of transforming thereof.
2, according to the method for claim 1.Used gene also comprises not through the insulin gene of transforming and part is transformed except through the transformed insulin gene of plant-preference cipher word.
3, according to the method for claim 1.Used gene comprises also that except 3 ' end has added the insulin gene of KDEL sequence 3 ' end does not add the gene of KDEL sequence and the gene that has added other like.
4, according to the method for claim 1.Used gene also comprises the method that adopts other amino acid to connect except adopting the method for 6 amino acid with INSULIN A, two chains connections of B.
5, according to the method for claim 1.The promotor that insulin gene adopts except the CaMV 35S promoter, also comprise other can be in plant expression promoter.
6, according to the method for claim 1.Acceptor also comprises other plants such as cucumber, Radix Dauci Sativae, tobacco except that romaine lettuce.
CN 02104176 2002-03-15 2002-03-15 Process for preparing human insuline from transgenic romaine lettuce Pending CN1382734A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN 02104176 CN1382734A (en) 2002-03-15 2002-03-15 Process for preparing human insuline from transgenic romaine lettuce
CNB031195857A CN100540666C (en) 2002-03-15 2003-03-12 Utilize transgenic lettuce, tomato and tobacco to produce insulin human's method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02104176 CN1382734A (en) 2002-03-15 2002-03-15 Process for preparing human insuline from transgenic romaine lettuce

Publications (1)

Publication Number Publication Date
CN1382734A true CN1382734A (en) 2002-12-04

Family

ID=4740020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02104176 Pending CN1382734A (en) 2002-03-15 2002-03-15 Process for preparing human insuline from transgenic romaine lettuce

Country Status (1)

Country Link
CN (1) CN1382734A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370919C (en) * 2006-01-23 2008-02-27 缪淑华 Ecological and nutritious mixing feed for cultivated german carp
CN1836047B (en) * 2003-06-17 2010-12-22 赛姆生物系统遗传公司 Methods for the production of insulin in plants
CN101684468B (en) * 2003-04-14 2011-11-16 林忠平 Synthetic human insulin gene and use thereof in cultivation of transgenic tomatoes
WO2014165297A1 (en) 2013-03-12 2014-10-09 HMI Medical Innovations, LLC Plant extracts with anti-diabetic and other useful activities
CN107236759A (en) * 2017-06-16 2017-10-10 深圳惠升生物科技有限公司 Application of the romaine lettuce as host in expressing protein and/or polypeptide
CN107254486A (en) * 2017-06-16 2017-10-17 深圳惠升生物科技有限公司 Application of the romaine lettuce as host in expression growth factor
CN109385443A (en) * 2017-08-07 2019-02-26 北京睿诚海汇健康科技有限公司 Application of the romaine lettuce as host in expression coagulation factor
CN109385441A (en) * 2017-08-07 2019-02-26 北京睿诚海汇健康科技有限公司 Application of the romaine lettuce as host in expression nerve growth factor
CN109385449A (en) * 2017-08-10 2019-02-26 北京睿诚海汇健康科技有限公司 Application of the plant as host in expression of insulin
CN109456397A (en) * 2017-09-06 2019-03-12 北京睿诚海汇健康科技有限公司 Application of the plant as host in expression of insulin like growth factor
US11633446B2 (en) 2017-05-12 2023-04-25 Housey Pharmaceutical Research Laboratories, L.L.C. Plant extracts with anti-diabetic and other useful activities

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101684468B (en) * 2003-04-14 2011-11-16 林忠平 Synthetic human insulin gene and use thereof in cultivation of transgenic tomatoes
CN1836047B (en) * 2003-06-17 2010-12-22 赛姆生物系统遗传公司 Methods for the production of insulin in plants
CN100370919C (en) * 2006-01-23 2008-02-27 缪淑华 Ecological and nutritious mixing feed for cultivated german carp
AU2018278958B2 (en) * 2013-03-12 2020-11-12 Hmi, Inc. Plant extracts with anti-diabetic and other useful activities
WO2014165297A1 (en) 2013-03-12 2014-10-09 HMI Medical Innovations, LLC Plant extracts with anti-diabetic and other useful activities
EP2968426A4 (en) * 2013-03-12 2016-10-12 Hmi Medical Innovations Llc Plant extracts with anti-diabetic and other useful activities
US11633446B2 (en) 2017-05-12 2023-04-25 Housey Pharmaceutical Research Laboratories, L.L.C. Plant extracts with anti-diabetic and other useful activities
CN107254486A (en) * 2017-06-16 2017-10-17 深圳惠升生物科技有限公司 Application of the romaine lettuce as host in expression growth factor
CN107236759A (en) * 2017-06-16 2017-10-10 深圳惠升生物科技有限公司 Application of the romaine lettuce as host in expressing protein and/or polypeptide
CN109385441A (en) * 2017-08-07 2019-02-26 北京睿诚海汇健康科技有限公司 Application of the romaine lettuce as host in expression nerve growth factor
CN109385443A (en) * 2017-08-07 2019-02-26 北京睿诚海汇健康科技有限公司 Application of the romaine lettuce as host in expression coagulation factor
CN109385441B (en) * 2017-08-07 2022-08-02 北京睿诚海汇健康科技有限公司 Application of lettuce as host in expressing nerve growth factor
CN109385443B (en) * 2017-08-07 2022-08-02 北京睿诚海汇健康科技有限公司 Application of lettuce as host in expression of blood coagulation factor
CN109385449A (en) * 2017-08-10 2019-02-26 北京睿诚海汇健康科技有限公司 Application of the plant as host in expression of insulin
CN109456397A (en) * 2017-09-06 2019-03-12 北京睿诚海汇健康科技有限公司 Application of the plant as host in expression of insulin like growth factor

Similar Documents

Publication Publication Date Title
KR0154872B1 (en) Agrobacterium mediated transformation of germinating plant seeds
DE60221051T2 (en) PREPARATION OF PEPTIDES AND PROTEINS BY TREATMENT IN PROTEIN BODIES DERIVED FROM ENDOPLASMIC RETICULUM
CN101065491B (en) Collagen producing plants and methods of generating and using same
CN1533438A (en) Method for producing proteins in plants
CN1382734A (en) Process for preparing human insuline from transgenic romaine lettuce
CN111748562B (en) Coding gene of Rhizoctonia solani Atg22 protein, target fragment Rsatg22 and application thereof
CN101628941B (en) Bovine lactoferrin antibacterial peptide fusion protein, coding gene and application thereof
CN102181456B (en) Cotton flowering hormone GhFT and vector, construct, cell and polypeptide thereof
EP0652955A1 (en) Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use
CN101210251A (en) Tobacco S-phase kinase-associated protein 1 gene sequence and its coding protein sequence and application
CN110041417A (en) A kind of hexose transport albumen and its encoding gene and application
CN1636056A (en) Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
CN100540666C (en) Utilize transgenic lettuce, tomato and tobacco to produce insulin human's method
CN101736029A (en) Method for producing human insulin-like growth factor-1 by vegetable oil ribosomal protein expression system
CN102559699A (en) CsCoL1 gene relative to cymbidium sinense photoperiod and application of CsCoL1 gene
CN101255420A (en) Method for preparation of transgenic rice preparation and use thereof
CN115058433B (en) Tobacco leaf yellowing regulatory gene NtMYB2, protein and application thereof
CN112458097B (en) Metallothionein DaMT2a and application of encoding gene thereof
CN114990140B (en) Cassava pyridoxal kinase gene and application thereof in improving salt tolerance of plants
CN112831502B (en) Metallothionein DaMT3a and application of encoding gene thereof
CN107384948A (en) In the high method for expressing target protein of plant and the preparation method of the Compositions for oral delivery for the medical protein for expressing plant
CN108103075A (en) A kind of switchgrass gene PvC3H29 for delaying plant senescence and its application
CN115704035B (en) Tobacco NtDSR2 gene and application thereof
CN117143832B (en) Insect-resistant protein Cry1Ah hybridoma cell strain, antibody produced by same and application thereof
CN116004711B (en) Rhizoma acori graminei rhizome gene silencing system based on VIGS and construction method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication